Full Text View
Tabular View
No Study Results Posted
Related Studies
Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension
This study has been completed.
Study NCT00023296   Information provided by National Institutes of Health Clinical Center (CC)
First Received: September 3, 2001   Last Updated: August 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sickle Cell Anemia
Pulmonary Hypertension
Additional conditions recognized in this trial
Anemia
Anemia, Sickle Cell
Hypertension
Hypertension, Pulmonary
More general conditions related to this trial
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Cardiovascular Diseases
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Nitric Oxide
INO Pulse - NO Delivery System
More general drug interventions related to this trial
Anti-Asthmatic Agents
Antioxidants
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Endothelium-Dependent Relaxing Factors
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services